Human RCAN3 gene expression and cell growth in endothelial cells

International Journal of Molecular Medicine

Volumn 26, Issue 6, 2010, Pages 913-918

  Canaider, Silvia ^a   Vettraino, Marina ^a   Norling, Lucy V ^b   Spisni, Enzo ^a   Facchin, Federica ^a   Cooper, Dianne ^b   Perretti, Mauro ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Human umbilical vein endothelial cells; Inflammation; Phorbol 12 myristate 13 acetate; Proliferation; Regulator of calcineurin 3; Vascular endothelial growth factor

Indexed keywords

4 O METHYLPHORBOL 13 ACETATE 12 MYRISTATE; CALCINEURIN; COMPLEMENTARY DNA; REGULATOR OF CALCINEURIN 3; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UMBILICAL VEIN;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL GROWTH PROCESSES; CELLS, CULTURED; CLONING, MOLECULAR; CYCLOOXYGENASE 2; CYTOKINES; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UMBILICAL VEINS;

EID: 78649946402     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000542     Document Type: Article

References (31)

1. Strippoli P, Lenzi L, Petrini M, Carinci P and Zannotti M: A new gene family including DSCR1 (Down Syndrome Candidate Region 1) and ZAKI-4: characterization from yeast to human and identification of DSCR1-like 2, a novel human member (DSCR1L2). Genomics 64: 252-263, 2000. (Pubitemid 30212626)
2. Davies KJA, Ermak G, Rothermel BA, et al: Renaming the DSCR1/Adapt78 gene family as RCAN - regulators of calcineurin. FASEB J 21: 3023-3028, 2007. (Pubitemid 47565558)
3. Fuentes JJ, Pritchard MA, Planas AM, Bosch A, Ferrer I and Estivill X: A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum Mol Genet 4: 1935-1944, 1995.
4. Miyazaki T, Kanou Y, Murata Y, Ohmori S, Niwa T, Maeda K, Yamamura H and Seo H: Molecular cloning of a novel thyroid hormoneresponsive gene, ZAKI-4, in human skin fibroblasts. J Biol Chem 271: 14567-14571, 1996. (Pubitemid 26190362)
5. Facchin F, Canaider S, Vitale L, Frabetti F, Griffoni C, Lenzi L, Casadei R and Strippoli P: Identification and analysis of human RCAN3 (DSCR1L2) mRNA and protein isoforms. Gene 407: 159-168, 2008. (Pubitemid 350251664)
6. Strippoli P, D'Addabbo P, Lenzi L, Giannone S, Canaider S, Casadei R, Vitale L, Carinci P and Zannotti M: Segmental paralogy in the human genome: a largescale triplication on 1p, 6p, and 21. Mamm Genome 13: 456-462, 2002. (Pubitemid 34809902)
7. Mulero MA, Aubareda A, Schluter A and Perez-Riba M: RCAN3, a novel calcineurin inhibitor that down-regulates NFAT-dependent cytokine gene expression. Biochim Biophys Acta 1773: 330-341, 2007.
8. Fuentes JJ, Genescà L, Kingsbury TJ, Cunningham KW, Pérez-Riba M, Estivill X and de la Luna S: DSCR1, overexpressed inDown syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9: 1681-1690, 2000. (Pubitemid 30427005)
9. Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R and Williams RS: A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 275: 8719-8725, 2000.
10. Aubareda A, Mulero MC and Perez-Riba M: Functional characterization of the calcipressin 1 motif that suppresses calcineurin-mediated NFAT-dependent cytokine gene expression in human T cells. Cell Signal 18: 1430-1438, 2006. (Pubitemid 43832079)
11. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR and Olson EN: A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998. (Pubitemid 28180855)
12. Bueno OF, Lips DJ, Kaiser RA, et al: Calcineurin A gene targeting predisposes the myocardium to acute ischemiainduced apoptosis and dysfunction. Circ Res 94: 91-99, 2004.
13. Aramburu J, Rao A and Klee CB: Calcineurin: from structure to function. Curr Top Cell Regul 36: 237-295, 2000.
14. Parsons SA, Millay DP, Wilkins BJ, et al: Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J Biol Chem 279: 26192-26200, 2004.
15. Zeng H, Chattarji S, Barbarosie M, et al: Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 107: 617-629, 2001. (Pubitemid 34014863)
16. Lee JI and Ahnn J: Calcineurin in animal behaviour. Mol Cell 17: 390-396, 2004.
17. Abe M and Sato Y: cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis 4: 289-298, 2001. (Pubitemid 34832374)
18. Liu D, Gia H, Holmes DI, Stannard A and Zachary I: Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler Thromb Vasc Biol 23: 2002-2007, 2003.
19. Yao Y-G and Duh EJ: VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis? Biochem Bioph Res Commun 321: 648-656, 2004.
20. Minami T, Horiuchi K, Miura M, et al: Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 279: 50537-50554, 2004.
21. Hesser BA, Liang XH, Camenisch G, et al: Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Blood 104: 149-158, 2004. (Pubitemid 38879851)
22. Gollogly LK, Ryeom SW and Yoon SS: Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis. J Surg Res 142: 129-136, 2007.
23. Spisni E, Griffoni C, Santi S, et al: Colocalization prostacyclin (PGI2) synthase - caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis. Exp Cell Res 266: 31-43, 2001. (Pubitemid 32989040)
24. Al-Nasiry S, Geusens N, Hanssens M, Luyten C and Pijnenborg R: The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod 22: 1304-1309, 2007. (Pubitemid 47062799)
25. Davuluri RV, Suzuki Y, Sugano S, Plass C and Huang TH: The functional consequences of alternative promoter use in mammalian genomes. Trends Genet 24: 167-177, 2008.
26. Yu Y, Moulton KS, Khan MK, Vineberg S, et al: E-selectin is required for the antiangiogenic activity of endostatin. Proc Natl Acad Sci USA 101: 8005-8010, 2004.
27. Barthel SR, Gavino JD, Descheny L and Dimitroff CJ: Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets 11: 1473-1491, 2007. (Pubitemid 350200482)
28. Hernández GL, Volpert OV, Iñiguez MA, et al: Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 193: 607-620, 2001.
29. Hamilton JA: GM-CSF in inflammation and autoimmunity. Trends Immunol 23: 403-408, 2002.
30. Daubie V, Pochet R, Houard S and Philippart P: Tissue factor: a mini-review. J Tissue Eng Regen Med 1: 161-169, 2007.
31. Canaider S, Facchin F, Griffoni C, Casadei R, Vitale L, Lenzi L, Frabetti F, D'Addabbo P, Carinci P, Zannotti M and Strippoli P: Proteins encoded by human Down syndrome critical region gene 1-like 2 (DSCR1L2) mRNA and by a novel DSCR1L2 mRNA isoform interact with cardiac troponin I (TNNI3). Gene 372: 128-136, 2006.